Peptides are short chains of amino acids that act as chemical messengers throughout your body, directing everything from blood sugar regulation to tissue repair. Your body produces thousands of them naturally, and they control some of the most fundamental processes keeping you alive: growth, metabolism, immune response, reproduction, and pain signaling. Outside the body, peptides show up in skincare products, pharmaceutical drugs, and a growing market of supplements and injectable compounds, each claiming to harness these signaling properties for specific benefits.
How Peptides Work in Your Body
Peptides function primarily as signaling molecules. They’re produced by glands and tissues, released into the bloodstream or surrounding area, and then lock onto specific receptors on target cells to trigger a response. Think of them as tiny instruction sets: each peptide carries a specific message to a specific type of cell, telling it to speed up, slow down, grow, or die.
Insulin is one of the most well-known peptide hormones. It’s a 51-amino-acid chain that binds to receptors on muscle and fat cells, causing them to open glucose channels and absorb sugar from the blood. Without it, blood sugar rises uncontrollably, which is the central problem in diabetes. Growth hormone, a larger peptide of about 200 amino acids, drives cell reproduction and tissue growth throughout childhood and continues to influence metabolism in adults. Oxytocin and antidiuretic hormone (ADH), produced in the brain’s posterior pituitary, differ by only two amino acids but have completely different jobs: oxytocin triggers uterine contractions and social bonding, while ADH tells the kidneys to retain water.
Other peptide hormones manage reproduction (FSH and LH control ovulation and sperm production), stress response (ACTH signals the adrenal glands to release cortisol), thyroid function (TSH tells the thyroid to produce its hormones), and calcium balance (parathyroid hormone pulls calcium from bones into the bloodstream when levels drop). Glucagon, insulin’s counterpart, raises blood sugar when it falls too low. These are just the major players. Your gut, brain, immune system, and skin all produce peptides with highly specific local effects.
Peptides in Skincare
Topical peptides in creams and serums work by mimicking the signaling peptides your skin cells already use. They fall into a few categories based on what they do. Signal peptides stimulate fibroblasts, the cells responsible for producing collagen and elastin, to ramp up production. This can improve skin firmness and elasticity over time. Carrier peptides deliver trace minerals like copper to skin cells, supporting the enzymatic processes involved in wound healing and tissue repair. Neurotransmitter-inhibiting peptides work differently: they reduce the signaling that causes facial muscles to contract, which can soften expression lines in a mechanism loosely similar to what Botox does, though far less potent. Enzyme inhibitor peptides slow the breakdown of existing collagen, helping preserve the structural proteins your skin already has.
The practical reality is that topical peptides face a significant delivery challenge. Your skin’s outer barrier exists specifically to keep foreign molecules out, so the amount of peptide that actually penetrates deep enough to reach living cells varies widely depending on the formulation. Products with smaller peptide fragments and penetration-enhancing ingredients tend to perform better, but results are gradual and modest compared to procedures like laser resurfacing or injectable treatments.
Peptide-Based Medications
Some of the most talked-about drugs in recent years are peptide-based. GLP-1 receptor agonists, the drug class that includes semaglutide and tirzepatide, mimic a natural gut peptide called glucagon-like peptide-1. This peptide normally gets released after you eat and does several things at once: it stimulates insulin release when blood sugar is high, slows stomach emptying so food is absorbed more gradually, reduces glucagon (the hormone that raises blood sugar), and acts on the brain’s hypothalamus to increase feelings of fullness. GLP-1 drugs also appear to protect insulin-producing cells in the pancreas by reducing cell death and promoting their growth.
These drugs were originally developed for type 2 diabetes, but their powerful appetite-suppressing effects led to their use for weight management. The combination of slowed digestion, reduced hunger signaling in the brain, decreased sugar production by the liver, and improved glucose uptake in muscles creates a broad metabolic shift that goes well beyond what a single-target drug could achieve.
Peptides for Tissue Repair
BPC-157, a peptide derived from a protein found in gastric juice, has drawn significant attention in sports medicine and recovery circles. In laboratory and animal studies, it promotes healing through several mechanisms. It increases the activity of receptors that drive new blood vessel formation, which is particularly relevant for tendons and ligaments that naturally have poor blood supply. It also stimulates fibroblast growth and collagen production through specific cell-signaling pathways, and it increases the expression of growth hormone receptors on fibroblasts, amplifying the body’s natural repair response.
Animal studies have shown that BPC-157 improves tendon-to-bone healing and enhances repair at the myotendinous junction, a common injury site, even in the presence of corticosteroids that would normally impair recovery. These findings are promising, but it’s worth knowing that BPC-157 has not been approved for human use, and most evidence comes from animal models rather than controlled human trials.
Peptides From Food
Your digestive system breaks dietary protein into peptides, and some of these fragments have biological activity beyond basic nutrition. The most studied food-derived peptides are those that inhibit ACE (angiotensin-converting enzyme), the same enzyme targeted by common blood pressure medications. ACE converts a relatively inactive molecule into angiotensin II, which constricts blood vessels and raises blood pressure. Peptides that block this conversion can have a mild blood-pressure-lowering effect.
Dairy is a particularly rich source. Fermented milk products like yogurt and kefir contain the peptides IPP (Ile-Pro-Pro) and VPP (Val-Pro-Pro), which have demonstrated antihypertensive effects in studies. Whey protein hydrolysates also contain active fragments. On the plant side, researchers have identified blood-pressure-lowering peptides in rice protein, soy, peas, oats, wheat bran, maize, and rapeseed. In hypertensive rats, peptides from rapeseed reduced blood pressure within two to four hours of oral administration. Beyond blood pressure, food-derived peptides have shown antioxidant, antimicrobial, and antithrombotic properties, though the effects are generally subtle compared to pharmaceutical interventions.
Why Absorption Matters
One of the biggest practical limitations of peptides is getting them into the body intact. Peptides are chains of amino acids, and your digestive system is specifically designed to break amino acid chains apart. When you swallow a peptide, stomach acid and digestive enzymes go to work on it immediately. Oral bioavailability, the percentage that actually reaches the bloodstream in active form, is remarkably low for most peptides. In clinical trials, oral octreotide capsules achieved only about 0.7% bioavailability. Even with advanced delivery systems like specialized microneedle devices, oral insulin has only reached around 10% bioavailability in experimental settings.
This is why most therapeutic peptides are given by injection, which bypasses the digestive system entirely. It’s also why oral peptide supplements should be viewed with some skepticism: the peptide you swallow is not necessarily the peptide that reaches your tissues. Some smaller peptides and certain formulations fare better than others, but the general principle holds. The food-derived peptides discussed above work partly because they’re small enough to resist complete digestion, but even they reach the bloodstream in limited quantities.
Safety and Regulation Concerns
The rapid growth of the peptide market has outpaced regulation. In 2024, the FDA flagged more than a dozen peptides commonly sold through compounding pharmacies as presenting significant safety risks. The list includes BPC-157, thymosin beta-4 (TB-500), several growth hormone-releasing peptides (GHRP-2, GHRP-6), CJC-1295, ipamorelin, and Melanotan II, among others.
The primary concern across nearly all of these is immunogenicity: the potential for injected peptides to trigger immune reactions, particularly when impurities or aggregated molecules are present in compounded products. Specific risks vary by peptide. Melanotan II, used for skin tanning, has been linked to melanoma, a dangerous brain swelling condition, and priapism. Ipamorelin has been associated with deaths when administered intravenously. CJC-1295 has caused rapid heart rate and dangerous drops in blood pressure. For many others on the list, like MOTS-c and TB-500, the FDA’s concern is simpler: there is essentially no human safety data at all.
FDA-approved peptide drugs like GLP-1 agonists and insulin go through rigorous testing for purity, dosing, and long-term safety. Compounded peptides purchased online or through wellness clinics do not undergo this level of scrutiny, and the gap between what’s been proven in animal studies and what’s safe for human injection remains wide for most of the popular performance and recovery peptides.